TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25818161

Group type: EXPERIMENTAL
Intervention: DHEA (100 mg/day)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: DHEA
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 24769385

Group type: EXPERIMENTAL
Intervention: GrandioSO (conventional viscosity)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: GrandioSO Heavy Flow (flowable viscosity)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Both materials (GrandioSO and GrandioSO Heavy Flow)
Number of subjects: 47
Study: 22685233

Group type: EXPERIMENTAL
Intervention: Subcutaneous glargine (0.25 U/kg body weight)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no glargine)
Number of subjects: 61
Study: 20368053

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (CFNB) after combined spinal and epidural anesthesia (CSEA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous femoral nerve block (CFNB) before combined spinal and epidural anesthesia (CSEA)
Number of subjects: 60
Study: 18657398

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 151

Group type: COMPARATOR
Intervention: Work therapy
Number of subjects: 151
Study: 15378185

Group type: EXPERIMENTAL
Intervention: Palladium-103 or iodine-125 seed implantation
Number of subjects: 38
Study: 11344179

Group type: COMPARATOR
Intervention: HRT-only (conjugated equine estrogens 0.625 mg)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Combined risedronate-HRT (risedronate 5 mg + conjugated equine estrogens 0.625 mg)
Number of subjects: 524

Group type: COMPARATOR
Intervention: HRT-only
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Combined risedronate-HRT
Number of subjects: 524
Study: 9699433

Group type: EXPERIMENTAL
Intervention: Restored NCCL with resin-modified polyalkenoate (glass-ionomer) cement (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Restored NCCL with adhesive composite resin system (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Unrestored NCCL (Group 3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with no NCCL (Group 4)
Number of subjects: 40
Study: 7859805

Group type: EXPERIMENTAL
Intervention: Neomycin (1.5 g per day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pravastatin and neomycin in combination
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sitostanol ester (1.5 g per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pravastatin alone
Number of subjects: 27

Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 27
Study: 2681592

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 10
Study: 200256

Group type: EXPERIMENTAL
Intervention: 100 microgram of ethinyl oestradiol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: graduated doses of mestranol up to 50 microgram
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: conjugated equine oestrogen (1.25 mg daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: oestrogen valerate (2 mg daily)
Number of subjects: 50
Study: 30832370

Group type: EXPERIMENTAL
Intervention: Indoor high temperature (28 °C, 32 °C, 36 °C, 38 °C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Forehead temperature
Number of subjects: 10
Study: 28274907

Group type: EXPERIMENTAL
Intervention: Mobile Device-Based Electronic Data Capture (mEDC) system
Number of subjects: 1333
Study: 25951506

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (oral administration); doses of 37.5, 50, and 62.5 mg dosed every 8, 12, and 24 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (intravenous administration); pharmacokinetics described by a linear 2-compartment model.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil; pharmacodynamic effect.
Number of subjects: 0
Study: 23442899

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor monotherapy
Number of subjects: 4041

Group type: COMPARATOR
Intervention: Baseline presence of suicidal ideation (SI)
Number of subjects: 4041
Study: 22043675

Group type: EXPERIMENTAL
Intervention: Warm needling therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Seretide inhalant
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 19735957

Group type: EXPERIMENTAL
Intervention: Jelly containing 5 g sc-FOS and 0.3 g Sideritis euboea extract
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 16500173

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RX) for 6 months including total body RX and isolated lumbar extension exercise
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nonexercising group (Control)
Number of subjects: 84
Study: 15727147

Group type: EXPERIMENTAL
Intervention: Fluconazole (0.2 g orally once a day)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Itraconazole (0.2 g orally twice a day)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ketoconazole (0.2 g orally twice a day)
Number of subjects: 88
Study: 11330886

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (mean DBP < or = 90 mmHg)
Number of subjects: 18790

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 18790
Study: 9217621

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg per day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 8131440

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 40
Study: 3520796

Group type: EXPERIMENTAL
Intervention: Ranitidine, 150 mg three times a day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31646393

Group type: EXPERIMENTAL
Intervention: Fractional 1064-nm Nd:YAG picosecond laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fractional 1550-nm erbium fiber laser
Number of subjects: 30
Study: 28258747

Group type: EXPERIMENTAL
Intervention: Psychotherapy with somatosensory stimulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 67
Study: 26964995

Group type: EXPERIMENTAL
Intervention: Elisidepsin (10 mg flat dose, Arm A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Elisidepsin (3.75 mg flat dose, Arm B)
Number of subjects: 44
Study: 23877137

Group type: EXPERIMENTAL
Intervention: Gain-framing with scripted parental mediation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Gain-framing
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Unscripted parental mediation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Scripted parental mediation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control (no mediation)
Number of subjects: 320
Study: 23494199

Group type: EXPERIMENTAL
Intervention: Tao Brush endometrial sampling on day 8-9 of the uterine cycle preceding stimulation (Group 2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tao Brush endometrial sampling on day 8-9 of the same IUI cycle (Group 3)
Number of subjects: 150

Group type: COMPARATOR
Intervention: IUI with no endometrial sampling (Group 1)
Number of subjects: 150
Study: 20229132

Group type: EXPERIMENTAL
Intervention: Interventions from medical care providers
Number of subjects: 3556

Group type: EXPERIMENTAL
Intervention: Prevention services from health educators, social workers, or paraprofessional HIV-infected peers
Number of subjects: 3556

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 3556
Study: 18954461

Group type: EXPERIMENTAL
Intervention: AR7 Joint Complex (1 capsule daily for 12 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (1 capsule daily for 12 weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AR7 Joint Complex
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 16842549

Group type: EXPERIMENTAL
Intervention: Coated pH 5.5 latex gloves
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard powder-free latex gloves
Number of subjects: 20
Study: 12523884

Group type: EXPERIMENTAL
Intervention: argon laser trabeculoplasty plus topical betaxolol
Number of subjects: 255

Group type: COMPARATOR
Intervention: no immediate treatment
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: IOP reduction from baseline to the first follow‐up visit
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: first IOP at 3 months' follow‐up
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: mean IOP at follow‐up
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: percent of patient follow‐up visits with disc hemorrhages
Number of subjects: 255
Study: 10351929

Group type: EXPERIMENTAL
Intervention: Inhalation of dry powder mannitol (approximately 300 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (baseline breathing maneuvers without mannitol)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Baseline (no intervention)
Number of subjects: 11
Study: 9015926

Group type: EXPERIMENTAL
Intervention: Acetaminophen method for gastric emptying of liquid food
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isotope method for gastric emptying of solid food
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Correlation with serum acetaminophen concentration (45 min value)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Correlation with % gastric retention of isotope (120 min value)
Number of subjects: 8
Study: 10147001

Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2860913

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atracurium (larger doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 0
Study: 31922272

Group type: EXPERIMENTAL
Intervention: Superficial Shaving combined with Photodynamic Therapy (SS‐PDT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 72
Study: 29370788

Group type: EXPERIMENTAL
Intervention: Single-dose radial extracorporeal shock wave therapy (rESWT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Local corticosteroid injection (LCsI)
Number of subjects: 25
Study: 26848262

Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol (UMEC/VI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium (TIO)
Number of subjects: 0
Study: 24902921

Group type: EXPERIMENTAL
Intervention: Active elastic compression stockings
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo elastic compression stockings
Number of subjects: 100
Study: 22632385

Group type: EXPERIMENTAL
Intervention: MI + CBT (n = 9)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: NDC + CBT (n = 10)
Number of subjects: 27

Group type: COMPARATOR
Intervention: TAU (n = 8)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: MI + CBT
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: NDC + CBT
Number of subjects: 27
Study: 20096137

Group type: EXPERIMENTAL
Intervention: Montessori activities (personalised one‐to‐one interaction activities based on Montessori principles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention (conversation or reading from and looking at pictures in a newspaper)
Number of subjects: 0
Study: 18570681

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) in individual format (10 sessions)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) in group format (10 sessions)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standardized recommended treatment for somatization disorder in primary care (Smith's norms)
Number of subjects: 204
Study: 17384957

Group type: EXPERIMENTAL
Intervention: Patients' perception of being involved in treatment
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Patients' feeling of being neglected by physicians
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Patients' perception of trust in physicians
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Perceived quality of psychosocial care
Number of subjects: 121
Study: 15471826

Group type: EXPERIMENTAL
Intervention: 18F-FDG PET
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Primary radiation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: SCC-Ag > or = 4 ng/mL
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Presence of symptoms at recurrence
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Risk score system
Number of subjects: 55
Study: 11302268

Group type: EXPERIMENTAL
Intervention: Supportive‐expressive therapy (SE)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Individual drug counseling (IDC)
Number of subjects: 308
Study: 9306425

Group type: EXPERIMENTAL
Intervention: Lumpectomy without radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lumpectomy with radiation
Number of subjects: 0
Study: 8324036

Group type: EXPERIMENTAL
Intervention: Temperature biofeedback
Number of subjects: 39

Group type: COMPARATOR
Intervention: Autogenic training
Number of subjects: 39
Study: 3731566

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg administered three times daily
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg daily
Number of subjects: 73
Study: 31877418

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 31544330

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study: 29198193

Group type: EXPERIMENTAL
Intervention: High-lipid and high-phospholipid diet (HL-HP diet, containing 20 % lipid and 8 % PL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-lipid and low-phospholipid diet (HL-LP diet, containing 20 % lipid and 1.5 % PL)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine (PC) treatment in primary hepatocytes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: siRNA for CTP: choline phosphate cytidylyltranferase α (CCTα) treatment in primary hepatocytes
Number of subjects: 12
Study: 25795256

Group type: EXPERIMENTAL
Intervention: MenABCWY formulation (full dose OMV)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: MenABCWY formulation (one-quarter dose OMV)
Number of subjects: 484

Group type: COMPARATOR
Intervention: MenACWY-CRM (control)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: MenABCWY formulations
Number of subjects: 484
Study: 24021044

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (TZP) 4.5 g, prolonged infusion every 6 hours for 3 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (TZP) 4.5 g, regular infusion every 6 hours for 30 minutes
Number of subjects: 50
Study: 21821328

Group type: EXPERIMENTAL
Intervention: Virtual reality navigation system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Freehand protocol
Number of subjects: 40
Study: 19452245

Group type: COMPARATOR
Intervention: Conventional disease-modifying anti-rheumatic drugs (DMARDs)
Number of subjects: 145
Study: 16794491

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 9995

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 9995
Study: 12738519

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11142581

Group type: EXPERIMENTAL
Intervention: recombinant alpha‐interferon 6 MU tiw plus ribavirin
Number of subjects: 100

Group type: COMPARATOR
Intervention: recombinant alpha‐interferon 6 MU tiw
Number of subjects: 100
Study: 9709273

Group type: EXPERIMENTAL
Intervention: Mammography and physical examination (MP)
Number of subjects: 50430

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 50430
Study: 8281731

Group type: EXPERIMENTAL
Intervention: Grade 6 readability material
Number of subjects: 85

Group type: COMPARATOR
Intervention: Grade 11 readability material
Number of subjects: 85

Group type: COMPARATOR
Intervention: Grade 9 readability material
Number of subjects: 85
Study: 3332805

Group type: EXPERIMENTAL
Intervention: Clonidine (average dose 0.4 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31582304

Group type: EXPERIMENTAL
Intervention: Subthreshold nanosecond laser (SNL) treatment
Number of subjects: 292

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 292
Study: 30039159

Group type: EXPERIMENTAL
Intervention: Oxygen (10 L per minute by nonrebreather facemask until delivery)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Room air (exposed to room air only without a facemask)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 114

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 114
Study: 26115789

Group type: EXPERIMENTAL
Intervention: Unmedicated ADHD patients
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Inattentive ADHD subtype
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Previous stimulant medication history
Number of subjects: 131

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 131
Study: 24081374

Group type: EXPERIMENTAL
Intervention: Bicyclol 25 mg three times daily
Number of subjects: 248

Group type: COMPARATOR
Intervention: Vitamin E (α-tocopherol) 100 mg three times daily
Number of subjects: 248
Study: 22523379

Group type: EXPERIMENTAL
Intervention: Arctic Front® catheter
Number of subjects: 32

Group type: COMPARATOR
Intervention: HD Mesh Ablator® catheter
Number of subjects: 32
Study: 20933558

Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 64

Group type: COMPARATOR
Intervention: No gum chewing
Number of subjects: 64
Study: 17629139

Group type: EXPERIMENTAL
Intervention: kinezitheraphy and functional electrical stimulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: kinezitheraphy
Number of subjects: 40
Study: 16223964

Group type: EXPERIMENTAL
Intervention: Intervention with a depression care-manager offering algorithm-based care for MDD
Number of subjects: 324

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 324
Study: 11733660

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol-alfentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane-N2O
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane-N2O
Number of subjects: 60
Study: 9868184

Group type: EXPERIMENTAL
Intervention: Beef tallow (BT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Corn oil (CO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-fiber diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-fiber diet
Number of subjects: 12
Study: 7846195

Group type: EXPERIMENTAL
Intervention: Milnacipran (100 mg/day)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 190
Study: 3247517

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Gated lung imaging
Number of subjects: 19
Study: 27515095

Group type: EXPERIMENTAL
Intervention: Radiofrequency neurotomy of the genicular nerves
Number of subjects: 73

Group type: COMPARATOR
Intervention: Intra-articular injection (2.5 mL of bupivacaine, 2.5 mg of morphine and 1 mL of betamethasone, 6 mL of fluid injection)
Number of subjects: 73
Study: 26686847

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg daily for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23264167

Group type: EXPERIMENTAL
Intervention: Bovine colostrum
Number of subjects: 9
Study: 22710607

Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/day p.o.) plus gemcitabine (1000 mg/m2, days 1, 8, 15, every 4 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Gemcitabine monotherapy
Number of subjects: 17
Study: 20074372

Group type: EXPERIMENTAL
Intervention: Intermittent screening and treatment (IST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent preventive treatment (IPT)
Number of subjects: 0
Study: 17573321

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study: 15652874

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11853070

Group type: EXPERIMENTAL
Intervention: New catheter
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard catheter
Number of subjects: 76

Group type: COMPARATOR
Intervention: Left-sided catheters
Number of subjects: 76

Group type: COMPARATOR
Intervention: Catheters inserted in females
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Catheters removed for poor blood flow
Number of subjects: 76

Group type: COMPARATOR
Intervention: Left-sided catheters and catheters in females
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Catheter design
Number of subjects: 76
Study: 11048608

Group type: EXPERIMENTAL
Intervention: Exemestane (aromatase inactivator)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Third-generation aromatase inhibitors
Number of subjects: 0
Study: 8790074

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 1340245

Group type: EXPERIMENTAL
Intervention: Oral hydration with rehydration salts
Number of subjects: 80

Group type: COMPARATOR
Intervention: Parenteral hydration
Number of subjects: 80
Study: 6147285

Group type: EXPERIMENTAL
Intervention: loprazolam (1.0 mg)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: nitrazepam (5.0 mg)
Number of subjects: 190

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 190
Study: 29851748

Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Exercise (HIFE) program, conducted in groups of 3 to 8 participants, led by two physiotherapists, 5 sessions (45 minutes each) per fortnight for 4 months (total 40 sessions).
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Exercise (HIFE) program.
Number of subjects: 93